NIGHTHAWK THERAPEUTICS Trademark

Trademark Overview

On Monday, January 3, 2022, a trademark application was filed for NIGHTHAWK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NIGHTHAWK THERAPEUTICS trademark a serial number of 97200471. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 20, 2025. This trademark is owned by Osprey Biopharmaceuticals, Inc.. The NIGHTHAWK THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceuticals
nighthawk therapeutics

General Information

Serial Number97200471
Word MarkNIGHTHAWK THERAPEUTICS
Filing DateMonday, January 3, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development services in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOsprey Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, January 6, 2022NEW APPLICATION ENTERED
Thursday, January 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2022ASSIGNED TO EXAMINER
Friday, October 7, 2022NON-FINAL ACTION WRITTEN
Friday, October 7, 2022NON-FINAL ACTION E-MAILED
Friday, October 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2023SUSPENSION LETTER WRITTEN
Monday, March 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 30, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, October 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 31, 2024NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 20, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 14, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 31, 2024NON-FINAL ACTION WRITTEN

Related Keywords

therapeutics nighthawk pharmaceuticals field services development research